Mariola Matysiak-Swiderek
Kosciuszki Street 4
Lodz, LD 90419, Poland
Lodz, LD 90419, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
A Long-Term Prospective Evaluation of the Predictive Value of Molecular Markers in Serum and Cerebrospinal Fluid in Patients in the Early Stage of Multiple Sclerosis.
Journal: International journal of molecular sciences
Published: March 03, 2026
CHI3L1 Expression in Neutrophils and Plasma of Multiple Sclerosis Patients: Implications for Pathogenesis and a Potential Biomarker.
Journal: International journal of molecular sciences
Published: February 01, 2026
Sleep Disorders in Neurodegenerative Diseases with Dementia: A Comprehensive Review.
Journal: Journal of clinical medicine
Published: August 31, 2025
Brain Atrophy and Cognitive Impairment in Primary and Secondary Progressive Multiple Sclerosis Cohort-Similar Progressive MS Phenotype.
Journal: International journal of molecular sciences
Published: July 25, 2025
Perspective of Disease and Treatment in Patients with Multiple Sclerosis: A Polish Multi-center Study.
Journal: Neurology and therapy
Published: July 11, 2025
Myotonia congenita - a diagnosis that can be made regardless of the patient's age.
Journal: Neurologia i neurochirurgia polska
Published: June 26, 2025
Polymorphisms in Base Excision Repair Genes and Association with Multiple Sclerosis in a Pilot Study on a Central European Population.
Journal: International journal of molecular sciences
Published: May 21, 2025
Oxidative DNA Damage and Repair Dynamics in Multiple Sclerosis: Insights from Comet Assay Kinetics, Base Excision Repair Gene Expression, and Genotype Analysis.
Journal: Biomolecules
Published: April 15, 2025
No Relation Between Cognitive Impairment, Physical Disability and Serum Biomarkers in a Cohort of Progressive Multiple Sclerosis Patients.
Journal: Biomolecules
Published: November 07, 2024
Differences in Brain Atrophy Pattern between People with Multiple Sclerosis and Systemic Diseases with Central Nervous System Involvement Based on Two-Dimensional Linear Measures.
Journal: Journal of clinical medicine
Published: November 02, 2023
Predictive value of brain atrophy, serum biomarkers and information processing speed for early disease progression in multiple sclerosis.
Journal: Frontiers in neurology
Published: May 15, 2023
Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement.
Journal: Biomedicines
Published: December 23, 2022
Last Updated: 09/26/2026